Jean Costentin, MD
Affiliations: | laboratoire de neuropsychopharmacologie expérimentale | Université de Rouen |
Google:
"Jean Costentin"Mean distance: 18.05 (cluster 11)
Children
Sign in to add trainee| Nicolas Torquet | research assistant | Université de Rouen | |
| Dominique Duterte-Boucher | grad student |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Costentin J. (2015) [Neurobiology of endocannabinoids and central effects of tetrahydrocannabinol contained in indian hemp]. Bulletin De L'AcadéMie Nationale De MéDecine. 198: 527-38; discussion 5 |
| Pelloux Y, Costentin J, Duterte-Boucher D. (2015) Differential involvement of anxiety and novelty preference levels on oral ethanol consumption in rats. Psychopharmacology. 232: 2711-21 |
| Viana AF, Costentin J, do Rego JC, et al. (2015) G-protein activation revealed by [35S]-GTPγS binding assay is involved on the antidepressant-like effect of Hypericum caprifoliatum and Hypericum polyanthemum cyclohexane extracts Brazilian Journal of Pharmacognosy. 25: 387-394 |
| Le Maître E, Dourmap N, Vilpoux C, et al. (2013) Acute and subchronic treatments with selective serotonin reuptake inhibitors increase Nociceptin/Orphanin FQ (NOP) receptor density in the rat dorsal raphe nucleus; interactions between nociceptin/NOP system and serotonin. Brain Research. 1520: 51-60 |
| Neveu C, Lefranc B, Tasseau O, et al. (2012) Rational design of a low molecular weight, stable, potent, and long-lasting GPR103 aza-β3-pseudopeptide agonist. Journal of Medicinal Chemistry. 55: 7516-24 |
| Billet F, Costentin J, Dourmap N. (2012) Influence of corticostriatal δ-opioid receptors on abnormal involuntary movements induced by L-DOPA in hemiparkinsonian rats. Experimental Neurology. 236: 339-50 |
| Stein AC, Viana AF, Müller LG, et al. (2012) Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs. Behavioural Brain Research. 228: 66-73 |
| Cravezic A, Fichna J, Gach K, et al. (2011) Effect of potent endomorphin degradation blockers on analgesic and antidepressant-like responses in mice. Neuropharmacology. 61: 1229-38 |
| Costentin J. (2009) [A new approach to antischizophrenic therapeutics: D2 dopamine receptor partial agonists]. Annales Pharmaceutiques Franã§Aises. 67: 310-9 |
| Bohn P, Le Fur N, Hagues G, et al. (2009) Rational design of central selective acetylcholinesterase inhibitors by means of a "bio-oxidisable prodrug" strategy. Organic & Biomolecular Chemistry. 7: 2612-8 |